Worldwide Clinical Trials has expanded the pharmacy at its Clinical Pharmacology Unit (CPU) in San Antonio, Texas. Completed in January 2024, the expanded pharmacy provides Worldwide’s customers with streamlined processes, as well as decreased timelines and costs. Key focus areas of the project were equipment upgrades, operational demand, workplace demand, and employee engagement, with an overall goal to enhance the customer experience.
“A common thread among our Worldwide team members is a passion to take care of our customers – we’re always looking for ways to improve our partnerships,” said Mike Mencer, Executive Vice President and General Manager, Early Phase. “As part of an ongoing $5 million upgrade to our CPU, this expansion aligns with our culture of quality and our dedication to continuous improvement and innovation to meet our customers’ growing needs as we work together to improve the lives of patients around the world.”
Pharmacy upgrades included end-of-life equipment replacements and relocation for an expanded footprint within the CPU.
“Expanding our pharmacy in size enables us to expand in volume, providing additional opportunities and efficiencies for our customers,” said Lona Sheeran, Sr. Vice President, Clinical Operations, Early Phase. “We can now manufacture onsite, in real time, for Phase 1 studies per FDA guidance, allowing our customers the option to pivot on their dose while their study is ongoing. This service is unique and can save our customers thousands of dollars and months of time – a huge advantage in this fast-paced industry.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!